Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19151,137,0.97 [0.84-1.12],0.691046507514574
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19978,153,1.05 [0.91-1.21],0.4856537190231152
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19775,1137,1.02 [0.97-1.07],0.4285102825536181
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,19990,294,1.00 [0.90-1.10],0.9817096632067528
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19401,2831,1.02 [0.98-1.05],0.3609980566369821
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19390,2871,0.99 [0.96-1.02],0.4971946876786126
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19813,855,0.98 [0.93-1.04],0.5325460049211151
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19931,66,0.83 [0.68-1.03],0.0864096897244277
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18135,888,0.98 [0.92-1.04],0.4547893265260037
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17479,973,0.97 [0.92-1.03],0.3392151035078928
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17309,197,0.98 [0.87-1.11],0.7389884966610898
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14051,1858,0.97 [0.94-1.01],0.1910916339148534
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17252,326,1.04 [0.95-1.14],0.4136096581524243
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19981,1023,0.99 [0.94-1.05],0.8171171801011148
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Mycoses,20064,368,0.97 [0.89-1.06],0.4933590658971646
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19354,716,1.01 [0.95-1.08],0.6639762304748951
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20000,986,0.97 [0.92-1.03],0.3253509051808756
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19113,155,1.04 [0.91-1.20],0.5351201175400446
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20099,42,1.09 [0.83-1.42],0.5358203360514286
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19868,854,0.97 [0.92-1.03],0.3472150863082417
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19919,54,1.29 [1.01-1.64],0.0389496037915351
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20039,98,1.10 [0.92-1.30],0.3040738107305909
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20024,83,1.15 [0.95-1.39],0.147614124080779
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19027,389,1.07 [0.98-1.17],0.1399936767044628
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18869,231,1.01 [0.90-1.13],0.8780178156586285
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19026,68,0.96 [0.78-1.18],0.7219936796153226
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20082,58,0.84 [0.67-1.05],0.118953213579119
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20051,121,1.03 [0.88-1.21],0.6993215527940035
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral warts,19975,45,1.10 [0.85-1.43],0.4553840935660787
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19975,45,1.03 [0.79-1.33],0.8500152389625598
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm,19840,293,1.01 [0.91-1.11],0.8634698784827918
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20040,42,1.05 [0.81-1.37],0.7244320561236677
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20007,47,1.03 [0.80-1.32],0.8162702497228178
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20061,102,1.01 [0.85-1.19],0.9394175348506192
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19780,1378,0.99 [0.95-1.04],0.826168014768743
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of meninges,20098,26,0.99 [0.71-1.38],0.9405186623935295
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20047,57,0.85 [0.68-1.06],0.1518034745008168
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20086,64,0.94 [0.76-1.16],0.559891119760596
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20076,381,0.99 [0.91-1.09],0.908704439457781
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Caecum,20079,288,1.03 [0.93-1.14],0.5860978871908527
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19988,63,0.99 [0.80-1.23],0.9566436609038096
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,20073,240,1.03 [0.92-1.15],0.5714245437447303
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Rectum,20035,350,0.93 [0.85-1.01],0.1002487473679984
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19994,631,1.01 [0.94-1.08],0.7544867514375315
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20062,465,1.02 [0.94-1.11],0.5999255250897253
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15659,64,0.95 [0.76-1.17],0.6070951475399498
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15657,62,0.83 [0.67-1.02],0.0788567622325092
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20071,80,0.93 [0.77-1.13],0.464535987811449
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma, any site",20071,77,0.93 [0.77-1.13],0.4943477482194294
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lung cancer and mesothelioma,13405,302,1.01 [0.92-1.11],0.856885438665444
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lymphoid leukaemia,15653,58,0.99 [0.79-1.25],0.9613743021190608
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15754,159,1.12 [0.98-1.29],0.0997891515233706
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15830,235,0.97 [0.87-1.09],0.6464709965246744
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15671,76,0.83 [0.69-1.01],0.0615619344536051
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15710,115,1.10 [0.94-1.30],0.2444214960868572
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15723,128,0.97 [0.83-1.13],0.6849160349835373
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15662,67,0.96 [0.78-1.18],0.7040259969885811
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16741,1146,0.96 [0.92-1.01],0.1489494553924278
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15716,121,0.92 [0.79-1.07],0.2792265426782845
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15690,95,1.08 [0.90-1.28],0.4239230012917031
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15698,103,1.11 [0.93-1.31],0.2494351505003539
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi,19998,142,0.96 [0.83-1.11],0.6111495847804082
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi of trunk,20073,83,1.05 [0.87-1.27],0.6178354598488123
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanoma in situ,15623,63,1.10 [0.89-1.37],0.3835944266116525
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15684,89,0.88 [0.73-1.05],0.1533317717408821
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15738,143,0.88 [0.76-1.01],0.0775616905764366
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15790,195,1.01 [0.89-1.14],0.9134390602077804
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15684,89,0.88 [0.74-1.06],0.1786096768001304
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Other benign neoplasms of skin,19991,123,1.04 [0.89-1.21],0.6215007711063889
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16602,1007,0.98 [0.93-1.03],0.4231126815078382
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16662,1067,0.99 [0.94-1.04],0.6134195812396048
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19877,244,0.96 [0.86-1.07],0.4960222052671935
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18675,65,1.12 [0.90-1.39],0.3014357698850545
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19689,56,1.09 [0.86-1.37],0.4752909949692407
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19657,2268,1.00 [0.97-1.04],0.9140737358819646
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19066,51,1.43 [1.11-1.83],0.0047893436773942
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19746,43,0.76 [0.59-0.97],0.0304950704175365
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19807,1197,1.01 [0.96-1.06],0.7070353174113039
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19805,1195,1.01 [0.96-1.06],0.7492540248713802
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18686,76,0.82 [0.68-0.99],0.0384236493791057
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19915,900,1.07 [1.01-1.13],0.0241699372071373
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19794,91,1.00 [0.84-1.20],0.9663059131102636
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19690,57,0.90 [0.72-1.13],0.3717141854292368
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19686,53,1.09 [0.86-1.39],0.4607751260370603
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19961,258,0.75 [0.68-0.84],7.978427542156828e-08
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20019,38,0.89 [0.68-1.17],0.3928453233251266
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19912,209,0.72 [0.64-0.80],1.135455906878398e-08
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19076,61,0.83 [0.67-1.03],0.090789430044974
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14899,300,0.98 [0.89-1.08],0.646200056948515
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18379,131,1.15 [0.99-1.34],0.0737043378446156
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18409,161,1.04 [0.91-1.19],0.5291702067992948
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14650,51,1.07 [0.84-1.36],0.6073910072596869
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18977,54,0.90 [0.71-1.13],0.3530913780223906
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18328,188,0.93 [0.82-1.05],0.2282676512049216
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19710,473,0.99 [0.92-1.08],0.8941084518141998
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19433,196,0.91 [0.80-1.03],0.1196750992785894
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19355,118,1.06 [0.90-1.24],0.4928142072444221
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19851,928,1.06 [1.00-1.12],0.0468860030207899
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17241,894,1.05 [0.99-1.11],0.1109682806449858
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14657,58,0.87 [0.70-1.09],0.2357124749886329
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19384,36,0.95 [0.72-1.27],0.7482677392018843
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14813,214,1.05 [0.93-1.18],0.4565359646820253
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14659,60,0.94 [0.75-1.17],0.583303521637025
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17819,3220,1.04 [1.01-1.08],0.0054913225772612
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14748,149,0.91 [0.79-1.04],0.1635524312123003
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15050,451,0.99 [0.92-1.08],0.8485020480303131
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20050,221,0.97 [0.87-1.09],0.6326525217270947
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19899,70,0.80 [0.65-0.97],0.0254149790795598
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14723,124,1.00 [0.86-1.17],0.9982949922558638
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14654,55,0.91 [0.72-1.14],0.3963512445544525
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19945,597,1.02 [0.95-1.09],0.607421516428571
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14851,252,1.05 [0.95-1.17],0.3481979138151342
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14885,286,0.84 [0.76-0.93],0.0004715431005735
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15202,603,1.08 [1.01-1.16],0.0261969751042068
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14711,112,0.94 [0.80-1.10],0.4290132918367334
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19893,64,0.79 [0.64-0.97],0.0271944365281275
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15089,490,1.09 [1.00-1.17],0.0372856130036424
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14925,326,1.01 [0.92-1.11],0.8563021877895515
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18188,48,1.08 [0.84-1.39],0.530281505923696
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18932,4333,1.02 [1.00-1.05],0.097665420288419
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19360,12,1.21 [0.73-2.02],0.4542081893628936
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19369,21,1.04 [0.72-1.52],0.8331990522349504
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19963,1489,0.97 [0.93-1.02],0.2172529302332139
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19959,1484,0.97 [0.93-1.02],0.2340184379919069
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19362,14,1.75 [1.08-2.83],0.0238994592675725
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19875,672,1.02 [0.96-1.09],0.5421202981882288
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15939,1340,1.00 [0.96-1.05],0.8884012250927668
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20090,198,0.87 [0.77-0.98],0.0184446377596401
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19321,84,0.87 [0.73-1.05],0.1458854093890319
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19265,62,1.05 [0.85-1.31],0.6358114209694106
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19276,73,1.30 [1.05-1.59],0.0139221756808898
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14657,58,1.13 [0.90-1.42],0.2997460593342388
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17752,144,0.99 [0.86-1.14],0.9079233863884688
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2132,103,0.96 [0.81-1.14],0.6327420818271923
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2268,265,0.95 [0.86-1.06],0.3658908923137658
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17690,82,1.03 [0.86-1.25],0.7318434317033073
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2085,56,0.87 [0.69-1.09],0.2149975591434657
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19456,1848,1.02 [0.98-1.07],0.2306727501891811
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19511,274,0.89 [0.80-0.98],0.0200002575812414
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18338,198,0.96 [0.85-1.08],0.4613573039697994
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15232,633,0.97 [0.91-1.04],0.433906662139357
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19991,207,0.88 [0.78-0.99],0.0331943707379711
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19095,231,0.91 [0.81-1.01],0.0774042368950308
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Angina pectoris,17691,1240,0.97 [0.92-1.01],0.1608621060968951
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19191,327,0.92 [0.83-1.01],0.0640657818355696
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18929,65,1.10 [0.89-1.35],0.3988267133175642
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19053,189,1.07 [0.94-1.21],0.3067935511712353
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11778,1911,0.95 [0.92-0.99],0.016536723890164
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,AV-block,16218,501,0.95 [0.88-1.02],0.1618804552580884
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20040,435,0.98 [0.90-1.06],0.5489288780589243
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,10078,211,1.02 [0.91-1.15],0.7139072385713578
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15887,170,0.87 [0.77-1.00],0.0423512128177622
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15807,90,0.85 [0.71-1.02],0.0769994007641294
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20099,48,1.03 [0.80-1.32],0.845281652517486
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Conduction disorders,16842,1125,0.95 [0.90-1.00],0.0389091935621372
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18636,2205,1.00 [0.96-1.04],0.9237818255733437
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17013,6585,1.01 [0.99-1.03],0.4802320112081734
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19061,228,0.88 [0.78-0.98],0.0210168611602888
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Endocarditis,15787,70,0.85 [0.69-1.03],0.1026718336536568
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19836,1107,0.99 [0.94-1.05],0.8276492863407771
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertension,18012,5720,1.03 [1.00-1.05],0.0288699088310513
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18017,5725,1.02 [1.00-1.05],0.0340701075840298
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19903,99,0.80 [0.68-0.95],0.0095925253081523
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12463,171,1.02 [0.90-1.17],0.7307360635258329
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12397,105,0.98 [0.83-1.16],0.8462708016680899
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypotension,19976,996,1.02 [0.96-1.07],0.5279222666125517
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19218,97,0.89 [0.75-1.06],0.187035911982862
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18752,2301,0.99 [0.96-1.03],0.7180399788572711
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19755,548,1.05 [0.98-1.13],0.1974110209899301
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16060,343,0.97 [0.88-1.06],0.490640546802964
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19515,896,1.01 [0.96-1.07],0.6767726669289813
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17228,777,1.02 [0.96-1.09],0.4707745817456606
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19962,194,1.02 [0.91-1.16],0.7096355465453071
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20056,315,1.01 [0.91-1.11],0.9100893049124604
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,18887,54,0.79 [0.63-0.98],0.0363344072154778
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other aneurysm,18943,79,1.09 [0.90-1.33],0.3684120260419923
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,16121,404,0.99 [0.91-1.07],0.7356436933357995
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18971,107,1.02 [0.87-1.20],0.7882287910929249
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19087,223,0.96 [0.86-1.08],0.4947539932219054
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15873,156,1.00 [0.87-1.15],0.9885217709969848
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,18910,77,0.94 [0.77-1.14],0.5187495685605055
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18875,42,1.10 [0.85-1.44],0.4684983158155573
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18810,73,1.12 [0.91-1.37],0.2913650439587303
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18920,87,0.95 [0.79-1.14],0.5910234587531251
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16749,1032,0.96 [0.91-1.01],0.1368859413673342
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19035,55,0.81 [0.65-1.02],0.0700822217680329
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19332,468,1.03 [0.95-1.12],0.4164358389354927
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19557,320,1.04 [0.94-1.15],0.4261859574876386
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19277,540,1.02 [0.95-1.10],0.6215011061854689
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10177,310,0.91 [0.83-1.01],0.0661001109989934
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19250,429,1.03 [0.95-1.12],0.4170286288622934
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19125,292,0.88 [0.79-0.97],0.0080350571439223
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19647,410,0.96 [0.88-1.04],0.2841123978827081
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20047,589,1.00 [0.93-1.07],0.8985047046599282
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16113,396,0.92 [0.85-1.01],0.071660333005423
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19556,319,1.04 [0.94-1.14],0.4745862278197732
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18918,181,1.03 [0.91-1.17],0.6100468198796085
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19743,622,1.03 [0.97-1.11],0.3372086431223424
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19732,646,1.03 [0.96-1.10],0.3960059511959459
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19201,37,0.90 [0.68-1.19],0.4514521660405001
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18958,95,0.83 [0.70-0.98],0.0310238620625991
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19403,196,1.06 [0.94-1.20],0.3487828805304565
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18876,257,1.02 [0.91-1.13],0.7683408006261079
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Varicose veins,19153,320,0.95 [0.86-1.04],0.2437559539457224
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18880,59,0.97 [0.78-1.21],0.770464775237569
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19890,641,0.92 [0.86-0.98],0.0154041910556967
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19931,415,1.00 [0.92-1.09],0.907439842262222
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17332,813,1.05 [0.99-1.11],0.1196241242002812
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Any mental disorder,19519,3000,1.01 [0.98-1.05],0.371545305967737
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19878,483,1.02 [0.94-1.10],0.6333555974695011
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17479,960,1.04 [0.98-1.10],0.1803159454174935
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16582,63,1.17 [0.94-1.46],0.1494914931414081
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Smoking dependency,19541,1287,1.01 [0.96-1.06],0.7047864126385666
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18077,1558,1.01 [0.97-1.05],0.668847351098654
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Vascular dementia,19714,116,0.88 [0.75-1.03],0.1242983871650176
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Alzheimer disease,20099,245,0.94 [0.84-1.05],0.2725015327456432
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13465,49,0.97 [0.75-1.24],0.7815096124314153
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Bell's palsy,18950,67,1.02 [0.83-1.26],0.838356239506908
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19174,291,1.07 [0.97-1.18],0.1882920321476329
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral cysts,19765,190,1.01 [0.90-1.15],0.8287299644127941
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20027,287,0.98 [0.89-1.08],0.687917333286338
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19695,55,1.07 [0.85-1.35],0.5715786304865961
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20084,66,0.83 [0.68-1.02],0.0773781679590048
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19649,74,1.02 [0.84-1.25],0.8271896066351926
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Epilepsy,18762,234,0.98 [0.88-1.10],0.774419479471125
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19653,1125,1.03 [0.98-1.08],0.2507613862593666
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20066,397,0.94 [0.86-1.03],0.1664068483732795
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19638,1779,0.97 [0.93-1.01],0.1674313870582004
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,19778,49,1.14 [0.89-1.47],0.2882728169808087
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hemiplegia,19963,223,1.01 [0.90-1.14],0.8228850403408225
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hydrocephalus,19624,49,1.06 [0.83-1.36],0.6331516463560123
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20084,53,1.21 [0.95-1.54],0.1166367171374277
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18902,19,0.78 [0.53-1.14],0.1958725839477278
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18960,77,0.91 [0.75-1.11],0.3483110785736785
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Memory loss,19583,105,0.91 [0.77-1.07],0.242200348353073
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Migraine,18689,161,1.13 [0.99-1.30],0.0690745394999214
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20081,147,1.14 [0.99-1.31],0.0757458251197076
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Motor neuron disease,13567,139,1.06 [0.92-1.23],0.4287235168044082
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19997,59,0.87 [0.70-1.09],0.222944729987024
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19696,813,1.03 [0.97-1.10],0.2709502197874145
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Neurological diseases,18984,2964,1.01 [0.97-1.04],0.7364630468232032
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19824,184,1.01 [0.89-1.14],0.8976050711001311
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19193,310,1.06 [0.96-1.17],0.2225149551885377
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20024,296,1.01 [0.91-1.11],0.8725778801881264
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15880,509,0.98 [0.90-1.05],0.5195790671671123
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19635,60,0.81 [0.65-1.00],0.0487312743121096
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19700,125,0.98 [0.84-1.15],0.8397236302950604
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19779,110,1.00 [0.85-1.18],0.9826621148650336
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18967,84,0.99 [0.82-1.19],0.909839067792955
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other headache syndromes,18562,34,1.00 [0.74-1.34],0.9857198740204668
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other neurological diseases,20001,426,1.00 [0.92-1.09],0.9941414684972424
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other sleep disorders,19107,579,1.03 [0.96-1.10],0.4465178865016249
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Parkinson's disease,20078,267,0.92 [0.83-1.03],0.1416536306373323
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19598,23,0.86 [0.61-1.23],0.4120589025290868
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,20098,37,1.07 [0.81-1.42],0.6268585000206321
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Sleep apnoea,19853,524,1.03 [0.95-1.11],0.4562724106630323
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19777,49,1.04 [0.81-1.33],0.7444856231323305
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20082,158,1.08 [0.94-1.24],0.2912364003986975
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18911,28,1.01 [0.73-1.40],0.9601891980533664
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20099,248,0.94 [0.84-1.05],0.2628065496827226
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19686,112,0.88 [0.75-1.03],0.1050255282342665
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19656,69,0.98 [0.80-1.20],0.8333691377892793
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19807,241,1.01 [0.90-1.13],0.8770164239778504
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19949,247,0.94 [0.84-1.04],0.2285678854477568
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19357,40,0.95 [0.72-1.24],0.6972236477448129
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19371,54,1.26 [0.99-1.60],0.058207671964894
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20021,34,0.98 [0.73-1.32],0.9077158013569342
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19912,101,1.09 [0.92-1.30],0.3166280035568019
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2085,56,0.85 [0.67-1.06],0.1487420563973851
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2539,108,0.97 [0.82-1.15],0.7453348336779264
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19667,80,1.27 [1.05-1.55],0.0163679779602795
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19911,843,1.02 [0.96-1.08],0.5911275301690613
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19841,524,1.00 [0.93-1.08],0.9543617100246982
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19430,113,0.99 [0.84-1.16],0.8997856450491426
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20036,470,1.04 [0.96-1.13],0.3395122121839379
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20097,55,1.10 [0.87-1.38],0.445580008219648
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19984,418,1.04 [0.95-1.13],0.3806781673686946
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20066,255,1.04 [0.93-1.15],0.5260362134689186
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20023,132,1.06 [0.91-1.23],0.437457304439598
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19384,67,1.14 [0.92-1.41],0.2290387505748673
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19393,76,0.90 [0.74-1.09],0.2727376698283124
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19351,34,0.97 [0.72-1.31],0.8526576293218555
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20019,572,1.01 [0.94-1.08],0.8371761398267756
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19611,164,0.97 [0.85-1.11],0.6279092248753629
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19589,23,0.76 [0.54-1.08],0.1253557739826945
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19892,81,0.98 [0.81-1.19],0.8621823238909354
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19990,179,1.03 [0.90-1.17],0.6883265443431583
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19716,150,1.10 [0.96-1.27],0.17530844249878
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19961,70,1.08 [0.88-1.33],0.4507740410942843
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19819,372,1.05 [0.96-1.15],0.2854941428479751
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19685,98,1.09 [0.91-1.29],0.350734490132966
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18968,1494,1.02 [0.97-1.06],0.5013022183696472
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19966,155,1.01 [0.88-1.16],0.8815341810917394
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20084,119,1.08 [0.92-1.26],0.3700090283230071
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19683,366,0.98 [0.90-1.07],0.6530237465118277
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19869,58,0.96 [0.77-1.21],0.7459572631606439
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20087,45,1.12 [0.87-1.46],0.3792537336515716
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19377,60,0.91 [0.73-1.13],0.3920505633104683
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19444,127,0.91 [0.78-1.06],0.2252363471547364
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19174,106,1.01 [0.85-1.19],0.9091277302555912
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19603,37,0.89 [0.67-1.17],0.3930802559917254
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19123,55,0.88 [0.70-1.11],0.2785115350706239
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19488,41,0.89 [0.68-1.16],0.3924988261677901
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19618,171,1.06 [0.93-1.22],0.3529291645149616
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19414,97,1.02 [0.86-1.22],0.8050240615655251
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19175,107,1.20 [1.02-1.42],0.031992458153525
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19143,75,0.97 [0.79-1.17],0.7247596686118758
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18675,1201,1.03 [0.98-1.08],0.2280916473218467
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19364,47,0.93 [0.72-1.19],0.5642625619432298
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19902,315,1.10 [1.00-1.21],0.0613337687850398
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19647,60,1.08 [0.86-1.35],0.4997161781474494
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19710,123,0.94 [0.81-1.09],0.4123895358056932
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19944,52,0.86 [0.68-1.09],0.2144039995039786
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20063,108,1.14 [0.96-1.34],0.1328484508915203
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19984,95,1.16 [0.97-1.38],0.1119376378737215
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19937,45,0.93 [0.72-1.19],0.5502772550299091
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19935,43,1.01 [0.78-1.31],0.9381277788245698
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20014,787,1.05 [0.99-1.12],0.1118248048561435
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19811,584,1.04 [0.97-1.12],0.227155634211834
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19334,107,0.92 [0.78-1.08],0.3114728835383988
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19297,70,1.14 [0.93-1.41],0.2015995749096394
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,19913,46,0.96 [0.74-1.23],0.7292043931169858
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20025,158,0.98 [0.85-1.12],0.7138931162683962
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19919,52,0.80 [0.64-1.01],0.061014423958068
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza,18212,85,1.07 [0.89-1.29],0.4814822446459802
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18209,82,1.11 [0.92-1.34],0.2940686353851248
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13189,86,1.10 [0.91-1.32],0.3328879915511248
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,20011,230,1.00 [0.89-1.12],0.998669865011246
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14030,1216,1.03 [0.98-1.08],0.2678469017192589
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14295,1192,1.03 [0.98-1.08],0.2482985190150254
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19766,123,1.07 [0.91-1.25],0.4161215531573067
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18202,75,1.15 [0.94-1.41],0.1650644903384466
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bronchiectasis,17455,244,1.02 [0.91-1.14],0.7600742008674897
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17247,36,1.38 [1.03-1.85],0.0317502867552774
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19373,2162,1.02 [0.99-1.06],0.2481465384714914
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18864,66,1.11 [0.89-1.37],0.3550252399907846
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,18927,129,1.05 [0.90-1.22],0.5486683103737618
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19910,1097,1.00 [0.95-1.06],0.874437559256057
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,18922,124,1.00 [0.86-1.16],0.9644792372837728
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18392,4411,1.00 [0.98-1.03],0.7472366005879152
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19137,339,1.00 [0.91-1.09],0.9625777811884608
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Early onset COPD,19084,271,0.95 [0.86-1.06],0.3714380422980233
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Emphysema,17518,307,1.00 [0.91-1.10],0.9764986935146376
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19299,301,1.01 [0.92-1.12],0.8345073995165042
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19889,1762,1.01 [0.97-1.05],0.6920545683742788
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,19321,323,1.03 [0.94-1.14],0.4893067839413139
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Later onset COPD,19158,826,1.03 [0.97-1.09],0.3481865513358743
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20083,331,1.04 [0.95-1.14],0.418765025377427
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Nasal polyp,18929,131,0.98 [0.85-1.14],0.8395502590575877
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19866,815,1.00 [0.94-1.07],0.9089649731998524
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,19866,1839,1.03 [0.99-1.07],0.1645544311763632
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19543,745,0.99 [0.93-1.06],0.8067348640649361
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other pleural conditions,18077,50,0.94 [0.74-1.19],0.6056314850156359
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20004,393,1.01 [0.93-1.10],0.7952904044817903
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19997,1171,1.04 [0.99-1.09],0.1236725213288717
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural effusion,18954,927,1.01 [0.96-1.07],0.6888705629057275
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural plaque,18252,225,0.99 [0.88-1.11],0.8706778653587203
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19677,1550,1.01 [0.96-1.05],0.7688817484687764
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19997,245,1.08 [0.96-1.20],0.184656462925444
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumothorax,18148,121,0.92 [0.79-1.07],0.2880901238696254
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pollen allergy,20085,199,1.05 [0.93-1.18],0.4572603937029776
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,19668,57,0.86 [0.69-1.07],0.1675709239420269
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13154,51,1.20 [0.94-1.53],0.1398121944559812
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19850,799,1.00 [0.94-1.06],0.9537932519978408
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19029,231,1.00 [0.90-1.12],0.9668735354985758
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Viral pneumonia,18350,223,1.01 [0.90-1.13],0.9177570640100288
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19786,190,0.97 [0.86-1.10],0.6099286106112061
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8805,96,0.92 [0.77-1.09],0.323697725920647
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14080,72,0.94 [0.77-1.15],0.559094251703466
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute appendicitis,19988,118,1.04 [0.89-1.22],0.6028153524261004
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute gastritis,15228,72,0.99 [0.81-1.21],0.9186240789391564
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,18945,173,0.93 [0.82-1.06],0.2532871899741353
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute peritonitis,19791,78,0.96 [0.79-1.17],0.7026277639977434
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19339,94,0.81 [0.68-0.96],0.0136182027035755
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,15599,443,0.96 [0.89-1.04],0.3257565168436703
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18875,103,0.94 [0.79-1.11],0.4510135978870042
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19758,103,0.94 [0.79-1.11],0.4348337603381998
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholecystitis,18957,185,0.90 [0.79-1.02],0.0955113355613049
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholelithiasis,19459,687,1.01 [0.94-1.08],0.8053300777945078
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic gastritis,15376,220,0.91 [0.81-1.02],0.0915191316464926
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18819,47,0.82 [0.65-1.05],0.1126784127112704
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19923,119,0.80 [0.68-0.93],0.0034748238835868
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Coeliac disease,18731,74,1.09 [0.89-1.34],0.3871326613226038
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Collagenous colitis,18883,40,1.00 [0.77-1.32],0.9715497717802956
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19956,183,0.89 [0.79-1.01],0.0665457868688547
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Constipation,19958,1299,1.00 [0.96-1.05],0.8926495502893202
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn disease,18919,76,1.05 [0.86-1.28],0.6157159843631366
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19807,55,1.07 [0.84-1.34],0.5958115426448813
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18907,64,1.10 [0.89-1.37],0.3837012265796813
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Dental caries,19556,185,1.04 [0.91-1.17],0.5858397402636438
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17035,1628,0.99 [0.95-1.04],0.7261734153393806
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of appendix,20013,143,1.01 [0.87-1.16],0.8986234024011308
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of liver,19980,735,0.93 [0.87-0.99],0.0160241856745249
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18406,3250,1.00 [0.97-1.03],0.9950870036567184
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19791,420,1.03 [0.95-1.12],0.4544977193697701
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20061,348,1.00 [0.91-1.09],0.9675530966338124
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19458,87,1.13 [0.94-1.37],0.1818050446852613
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19348,51,1.10 [0.86-1.39],0.4606776921981609
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19834,1177,1.01 [0.96-1.06],0.6574277581096577
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of tongue,19357,93,1.08 [0.90-1.29],0.4242759233575028
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19803,1031,0.97 [0.92-1.03],0.3491599869769284
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16580,2572,0.98 [0.95-1.02],0.2785924731973296
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,15370,214,0.97 [0.86-1.09],0.5614031582792118
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19998,166,1.00 [0.88-1.14],0.973963089965666
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20042,34,1.26 [0.93-1.70],0.1359204892112693
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19382,137,0.85 [0.73-0.98],0.023066643560234
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14156,148,0.88 [0.77-1.02],0.0822969714760791
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,15508,352,0.98 [0.89-1.07],0.6492864705664212
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastric ulcer,15462,306,1.01 [0.92-1.12],0.8168758967323162
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16954,1798,1.01 [0.97-1.05],0.5353139166532455
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15646,490,1.00 [0.92-1.08],0.9164716390309338
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15372,6690,1.00 [0.98-1.02],0.847191910013117
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,GI-bleeding,19631,974,0.99 [0.93-1.04],0.5983264875077299
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19416,45,1.08 [0.83-1.40],0.5631288183039387
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14790,1015,0.96 [0.91-1.01],0.1078274150147621
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19316,71,0.89 [0.73-1.09],0.2533692489095319
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Hernia,18364,2957,1.01 [0.98-1.04],0.5488241371958228
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impacted teeth,20045,33,1.29 [0.95-1.76],0.1014993565646397
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impaction of intestines,14046,38,0.82 [0.63-1.08],0.1676202237744951
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Inguinal hernia,16784,1377,1.01 [0.97-1.06],0.5583491908493613
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15570,163,1.01 [0.88-1.16],0.8682291896116074
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14083,75,0.89 [0.73-1.08],0.2272938444248464
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18744,87,1.13 [0.94-1.36],0.1987266598847855
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14243,235,0.97 [0.87-1.08],0.5737500237029916
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20062,315,0.98 [0.89-1.08],0.6771209925459599
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19410,567,1.00 [0.93-1.07],0.8920999601904118
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19588,745,0.98 [0.92-1.04],0.5569520879169381
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15331,175,0.92 [0.81-1.04],0.1868625155403491
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophagitis,15682,526,1.05 [0.98-1.14],0.1616629114009672
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20051,94,1.04 [0.87-1.24],0.678020601047113
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15464,57,1.22 [0.96-1.54],0.0972129625948635
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15212,1204,0.99 [0.95-1.04],0.7973025028699784
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18990,218,0.95 [0.85-1.07],0.411180781859885
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18875,103,0.94 [0.80-1.11],0.4732532650535798
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,15597,1589,0.98 [0.93-1.02],0.2627317881375546
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,18559,4551,0.98 [0.95-1.00],0.0511823372081447
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19328,153,1.09 [0.95-1.25],0.2262579799677411
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of liver,19835,590,0.90 [0.84-0.97],0.0035189944029402
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15776,620,0.97 [0.91-1.04],0.4284040085964578
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18885,113,0.96 [0.82-1.13],0.6568951655040259
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20004,291,1.01 [0.92-1.12],0.7790534163568753
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15821,665,0.96 [0.90-1.02],0.1943551593766362
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19640,983,0.99 [0.93-1.04],0.6032423313605755
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19516,145,1.01 [0.87-1.16],0.909222566748672
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15337,1329,0.99 [0.94-1.04],0.6216917438389051
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16724,1568,0.97 [0.93-1.01],0.1804617228334395
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19325,80,0.82 [0.68-0.99],0.0344912009316674
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19493,650,0.98 [0.91-1.04],0.4593095739279608
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14299,291,1.01 [0.91-1.11],0.9222506982623108
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20033,42,1.21 [0.92-1.58],0.1745119967969348
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14402,394,0.99 [0.90-1.08],0.758308245168399
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18799,142,1.15 [0.99-1.33],0.0629427999198457
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20085,34,0.86 [0.65-1.16],0.3249048190563403
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19376,80,1.10 [0.91-1.34],0.314917546508605
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Toxic colitis,18881,38,0.78 [0.59-1.02],0.0694191208891445
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15414,258,1.00 [0.90-1.12],0.9350252864041688
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,18969,126,0.98 [0.84-1.14],0.7837407287292039
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18947,104,0.95 [0.80-1.12],0.5247888752711196
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Umbilical hernia,15708,301,0.98 [0.89-1.08],0.6980114239322179
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14139,131,0.93 [0.80-1.08],0.3569970137033954
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ventral hernia,15623,216,1.07 [0.95-1.20],0.2658745735835595
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Volvulus,14066,58,0.94 [0.75-1.18],0.6201819568864707
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20045,273,0.92 [0.83-1.02],0.1054178804226767
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19835,58,1.18 [0.94-1.49],0.1528547015337628
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18465,76,1.00 [0.82-1.22],0.9767693630836392
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19476,639,0.96 [0.90-1.03],0.2448698234645799
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19007,170,1.04 [0.91-1.18],0.5866865029704738
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18753,364,0.96 [0.88-1.05],0.397329054370844
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19854,226,1.05 [0.94-1.18],0.3747940672412536
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20016,388,1.06 [0.97-1.15],0.218652970087112
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19667,39,1.22 [0.92-1.61],0.1707023023815768
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18835,2627,0.98 [0.95-1.01],0.2203735838883506
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19711,335,0.98 [0.90-1.08],0.7282609868495685
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19613,237,0.98 [0.88-1.10],0.7497980325605523
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19701,864,0.97 [0.92-1.03],0.3015847676348827
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20089,24,1.07 [0.75-1.53],0.6981635048077803
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18412,23,1.20 [0.83-1.73],0.3302447774431629
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19428,52,0.94 [0.74-1.19],0.6207295258406573
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19850,222,1.05 [0.93-1.18],0.4169289247277946
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18789,400,0.95 [0.88-1.04],0.2755008424048221
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18455,66,0.90 [0.73-1.11],0.330568839360136
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20042,71,1.00 [0.81-1.22],0.980993964258671
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19003,166,1.07 [0.94-1.23],0.3011402132994407
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19957,180,1.05 [0.92-1.19],0.4508963347089029
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19686,58,0.93 [0.74-1.16],0.5176041133590037
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18442,53,0.83 [0.66-1.04],0.1073538405198321
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19715,1326,0.97 [0.93-1.02],0.2221506555778394
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18824,435,0.96 [0.89-1.05],0.384492705841946
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18458,69,0.92 [0.75-1.13],0.4256879736433713
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20024,247,1.09 [0.98-1.22],0.1277248914438406
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19671,43,1.23 [0.94-1.61],0.129302499889211
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19994,217,1.10 [0.98-1.24],0.0980911793982287
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20061,289,0.91 [0.83-1.01],0.0725068252294175
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18461,72,1.02 [0.84-1.25],0.8237848279910054
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18610,221,0.89 [0.79-1.00],0.0433096012842494
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20055,283,0.91 [0.83-1.01],0.0794417548760557
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18597,208,0.99 [0.88-1.12],0.8886803303367498
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20076,105,1.04 [0.88-1.24],0.6082755579829988
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17335,69,0.93 [0.76-1.14],0.500200370504568
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18335,3996,1.03 [1.00-1.06],0.0441555810210932
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17148,2809,1.02 [0.99-1.05],0.2199685256024834
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17329,63,1.00 [0.80-1.23],0.9685796524604914
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17689,119,1.00 [0.86-1.17],0.9630665275991128
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17687,117,1.02 [0.87-1.20],0.7895842576577223
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19927,54,0.98 [0.77-1.23],0.8299240831877767
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17633,63,0.88 [0.71-1.09],0.2330862363963808
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15070,731,1.06 [0.99-1.13],0.0930794191313242
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19999,124,1.03 [0.88-1.20],0.7024458244233809
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17789,219,1.04 [0.92-1.17],0.5233784256235302
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17112,5239,1.02 [1.00-1.05],0.0448611179466018
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19230,85,0.86 [0.72-1.03],0.1024059765954445
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17402,136,0.85 [0.74-0.99],0.0327545551359074
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17642,376,1.07 [0.98-1.17],0.1129732717609412
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19402,1832,1.00 [0.96-1.04],0.9843116647116802
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17582,316,0.99 [0.90-1.09],0.8448965511995505
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17311,45,1.23 [0.95-1.59],0.1240677044119328
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17347,81,1.06 [0.88-1.29],0.5270053507163649
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19828,26,1.11 [0.79-1.56],0.5490759309783697
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15546,1207,1.02 [0.97-1.07],0.4711736630383062
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15148,809,1.05 [0.99-1.12],0.1015744444266152
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19979,797,1.06 [0.99-1.12],0.0762847424820901
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14377,38,0.83 [0.63-1.10],0.1964766442599566
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14406,67,1.04 [0.84-1.29],0.6979557284591615
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17485,219,1.05 [0.93-1.17],0.4539173669309444
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14866,527,1.03 [0.95-1.11],0.476495137846157
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17604,34,1.17 [0.87-1.58],0.3039088049381174
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18006,436,0.95 [0.88-1.03],0.2517435754093401
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17785,215,1.03 [0.92-1.16],0.5887609821062441
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14830,491,1.01 [0.93-1.09],0.8670167843150625
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17319,53,1.17 [0.92-1.49],0.1964285487015274
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17307,41,1.01 [0.77-1.32],0.9363165817062516
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19222,77,0.97 [0.80-1.17],0.7205149917938933
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19859,714,0.93 [0.87-0.99],0.0216608172689285
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19471,326,0.91 [0.83-1.00],0.0542247551307538
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20034,244,1.10 [0.98-1.23],0.0991489803662618
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15899,1560,1.03 [0.99-1.08],0.1426216444702344
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14385,46,0.93 [0.73-1.20],0.5948988974342799
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17331,65,1.04 [0.84-1.28],0.7508400216600737
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14385,46,0.97 [0.75-1.25],0.8194101895993788
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14377,38,0.93 [0.71-1.23],0.6130606761471173
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19298,153,0.94 [0.82-1.08],0.4081383737010432
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19282,137,0.93 [0.80-1.08],0.3274612555994675
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20070,69,1.12 [0.91-1.37],0.3012932704492833
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18829,1259,1.00 [0.95-1.05],0.8962728106615014
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17319,53,1.19 [0.93-1.51],0.1625580721873658
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14374,35,1.16 [0.86-1.56],0.337390031358611
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18085,515,1.03 [0.96-1.11],0.4105762564295361
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15764,1425,1.03 [0.98-1.08],0.2364705380440803
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19847,45,1.22 [0.94-1.58],0.1368446282902357
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20086,52,1.20 [0.94-1.53],0.1432312527540254
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17336,70,1.00 [0.82-1.23],0.9644277524430696
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18087,821,1.05 [0.99-1.12],0.1019275613578196
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17343,77,0.86 [0.71-1.05],0.1330054574120855
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15362,1023,1.01 [0.96-1.06],0.7852464858780779
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19215,70,0.88 [0.72-1.07],0.2061519893019067
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17304,38,1.33 [1.00-1.78],0.0533372317768717
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17662,92,0.93 [0.78-1.11],0.420335929346773
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17685,419,1.02 [0.94-1.11],0.6164170756753586
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19961,159,1.02 [0.89-1.17],0.7352972125275039
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17976,406,0.97 [0.89-1.06],0.4998755435380713
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20042,241,1.08 [0.97-1.21],0.172900772111277
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20086,31,1.11 [0.82-1.52],0.4988504006718286
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17395,129,1.00 [0.86-1.17],0.9593106750607014
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16500,474,1.07 [0.98-1.15],0.1145116897103396
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17665,399,1.01 [0.93-1.10],0.8549670373491505
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17552,286,0.96 [0.87-1.07],0.4846085433341895
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14364,25,1.16 [0.81-1.64],0.4165981058009197
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16239,1900,1.04 [1.00-1.08],0.0454893317971138
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14704,365,0.94 [0.86-1.03],0.1592845698986923
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19934,132,0.98 [0.85-1.14],0.8336490307770493
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20038,37,1.04 [0.78-1.38],0.7808000951224874
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18452,35,1.28 [0.95-1.73],0.1047273241051352
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14393,54,1.20 [0.95-1.52],0.1306658636975526
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17643,73,1.13 [0.92-1.38],0.2547753647279108
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14590,251,1.10 [0.98-1.22],0.0965342901401346
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17508,242,1.12 [1.00-1.25],0.0479486290548103
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17747,177,1.12 [0.98-1.27],0.091663422332388
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17640,70,0.95 [0.78-1.17],0.628021948105639
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15980,25,1.33 [0.94-1.90],0.1094322415489542
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20088,33,1.12 [0.83-1.51],0.4727079920508901
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17708,442,1.04 [0.96-1.13],0.3291565815168706
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19819,17,1.17 [0.76-1.78],0.4745125760015507
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19185,1919,1.03 [0.99-1.07],0.1201821571762231
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17355,89,1.19 [0.99-1.43],0.0687839730328043
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17976,406,1.01 [0.92-1.10],0.886885802484396
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19192,165,1.01 [0.89-1.16],0.8522615962998499
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17687,117,1.05 [0.90-1.23],0.5338415992622145
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18646,1076,1.02 [0.97-1.07],0.5117680824356226
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18239,669,1.01 [0.95-1.08],0.6617432200376038
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17297,31,1.05 [0.77-1.43],0.7616425006328722
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19839,37,1.18 [0.89-1.57],0.2563957718067431
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17373,107,1.26 [1.06-1.49],0.0074251019325331
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17285,19,1.10 [0.74-1.64],0.6318028835870958
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14390,51,1.02 [0.81-1.30],0.8472158602299972
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19356,1501,0.98 [0.94-1.03],0.4488927534688706
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19705,336,0.96 [0.87-1.05],0.3364300757329184
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19491,122,0.99 [0.85-1.16],0.8965406016255174
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18982,1127,0.94 [0.89-0.99],0.010910128624684
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19901,46,0.73 [0.57-0.93],0.0103649214347159
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19890,283,0.96 [0.87-1.06],0.4040335561306497
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cystitis,17749,172,1.02 [0.90-1.17],0.7407448108365645
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Dialysis,17923,68,1.12 [0.91-1.38],0.2997974165536756
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19048,2777,1.01 [0.98-1.04],0.5984229387386599
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18173,4653,0.99 [0.97-1.02],0.4525649160685211
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19925,70,0.97 [0.79-1.19],0.7947652859398612
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,16440,169,1.04 [0.91-1.18],0.5999903671194802
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17920,289,1.09 [0.98-1.20],0.1149517769501852
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18448,2177,1.00 [0.97-1.04],0.8840904629344756
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16465,194,0.92 [0.81-1.04],0.1608898187330145
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17635,58,0.95 [0.76-1.19],0.6582173762706423
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16371,100,0.88 [0.74-1.04],0.1390345435642429
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20092,52,1.01 [0.80-1.28],0.93569892346447
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20090,44,0.84 [0.65-1.08],0.1793284241355608
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19405,1828,0.97 [0.93-1.01],0.1436362703509568
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18375,798,0.94 [0.89-1.00],0.0466490885768217
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20041,434,0.98 [0.90-1.06],0.6384363827927417
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16529,258,1.00 [0.90-1.11],0.9633702621099806
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16507,236,0.99 [0.88-1.11],0.852704031072606
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16459,188,1.02 [0.90-1.16],0.7721120158684597
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20088,41,1.00 [0.76-1.30],0.9833712714616204
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18800,1223,0.99 [0.94-1.04],0.6811525476909461
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17954,323,1.06 [0.96-1.17],0.2469850560987695
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19753,146,0.99 [0.86-1.14],0.8871035108008126
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19907,52,0.84 [0.66-1.06],0.1403061016420445
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16492,221,1.03 [0.92-1.16],0.6037518017296526
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19881,2250,0.98 [0.95-1.02],0.2809995355267091
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17686,55,0.96 [0.76-1.21],0.7412561364407402
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17970,115,0.93 [0.79-1.08],0.3382540559356508
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19431,62,1.04 [0.84-1.29],0.7331157743148566
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17822,245,1.00 [0.90-1.12],0.9964676765684822
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19808,439,0.96 [0.89-1.04],0.3397833286783002
